Azapropazone: Difference between revisions
No edit summary |
No edit summary |
||
Line 7: | Line 7: | ||
| width = 200px | | width = 200px | ||
| imagename = 1 : 1 mixture (racemate) | | imagename = 1 : 1 mixture (racemate) | ||
| image2 = | | image2 = Azapropazone_3D_spacefill.png | ||
| alt2 = Azapropazone molecule | | alt2 = Azapropazone molecule | ||
| drug_name = Azapropazone | | drug_name = Azapropazone | ||
Line 61: | Line 61: | ||
| molecular_weight = 300.36 g/mol | | molecular_weight = 300.36 g/mol | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Azapropazone''' is a [[non-steroidal anti-inflammatory drug]]. It is manufactured by [[Goldshield]] under the tradename '''Rheumox'''.<ref>http://home.intekom.com/pharm/cont_eth/rheumox.html</ref> | '''Azapropazone''' is a [[non-steroidal anti-inflammatory drug]]. It is manufactured by [[Goldshield]] under the tradename '''Rheumox'''.<ref>http://home.intekom.com/pharm/cont_eth/rheumox.html</ref> | ||
Line 69: | Line 74: | ||
==References== | ==References== | ||
{{Reflist}} | {{Reflist|2}} | ||
{{Anti-inflammatory and antirheumatic products}} | {{Anti-inflammatory and antirheumatic products}} | ||
Line 77: | Line 82: | ||
[[Category:Non-steroidal anti-inflammatory drugs]] | [[Category:Non-steroidal anti-inflammatory drugs]] | ||
[[Category:Lactams]] | [[Category:Lactams]] | ||
[[Category:Drug]] | |||
Revision as of 20:09, 10 April 2015
File:Azapropazone.svg | |
Clinical data | |
---|---|
Trade names | Rheumox |
AHFS/Drugs.com | International Drug Names |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Elimination half-life | 20 hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C16H20N4O2 |
Molar mass | 300.36 g/mol |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
WikiDoc Resources for Azapropazone |
Articles |
---|
Most recent articles on Azapropazone Most cited articles on Azapropazone |
Media |
Powerpoint slides on Azapropazone |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Azapropazone at Clinical Trials.gov Clinical Trials on Azapropazone at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Azapropazone
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Azapropazone Discussion groups on Azapropazone Patient Handouts on Azapropazone Directions to Hospitals Treating Azapropazone Risk calculators and risk factors for Azapropazone
|
Healthcare Provider Resources |
Causes & Risk Factors for Azapropazone |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Azapropazone is a non-steroidal anti-inflammatory drug. It is manufactured by Goldshield under the tradename Rheumox.[1]
It was available in the UK as a prescription-only drug, with restrictions due to certain contra-indications and side-effects.[2] Azopropazone has now been discontinued in the British National Formulary.
Azapropazone has a half-life of approximately 20 hours in humans and is not extensively metabolized.[3]
References
- ↑ http://home.intekom.com/pharm/cont_eth/rheumox.html
- ↑ http://www.patient.co.uk/showdoc/30002267/
- ↑ Jones CJ (1976). "The pharmacology and pharmacokinetics of azapropazone - a review". Curr Med Res Opin. 4 (1): 3–16. doi:10.1185/03007997609109361. PMID 770078.
- Pages with script errors
- Pages with broken file links
- Template:drugs.com link with non-standard subpage
- Articles with changed CASNo identifier
- Articles with changed EBI identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Infobox drug articles with non-default infobox title
- Chemical pages without DrugBank identifier
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Triazines
- Non-steroidal anti-inflammatory drugs
- Lactams
- Drug